Two strategies for targeting the mTOR signaling pathway:Inhibiting the tumor mTOR signaling pathway to reduce resource depletion in the TME;Enhancing NK cell metabolism directly by activating the PI3K–Akt–mTOR signaling pathway via BPQDs@HSA. This evidence concerns the gene AKT1 and neoplasm.